Day One Biopharmaceuticals, (DAWN) Institutional Ownership
Track institutional investors, ownership changes, and 13F filings.
Ownership Summary
Total Institutions
173
Total Shares Held
93.74M
Total Value
$1.19B
Institutional Holding %
97.02%
Ownership Distribution
Top 5 Holders
Top Institutional Holders (as of Dec 31, 2024)
| Institution | Shares | Ownership % | Value |
|---|---|---|---|
| FMR | 12.89M | 13.34% | $163.28M |
| ATLAS VENTURE LIFE SCIENCE | 6.43M | 6.66% | $81.47M |
| BlackRock | 6.16M | 6.37% | $77.99M |
| VANGUARD | 5.85M | 6.05% | $74.11M |
| RA | 5.76M | 5.96% | $72.92M |
| BRAIDWELL | 4.87M | 5.04% | $61.75M |
| FRANKLIN RESOURCES | 3.88M | 4.02% | $49.20M |
| ESTUARY | 3.72M | 3.85% | $47.09M |
| PICTET ASSET | 3.49M | 3.61% | $44.22M |
| FAIRMOUNT FUNDS | 3.10M | 3.21% | $39.32M |
Recent Insider Trading
| Insider | Title | Transaction | Shares | Value | Date |
|---|---|---|---|---|---|
| Merendino Lauren | Chief Commercial Officer | - | $- | Feb 26, 2025 | |
| Merendino Lauren | Chief Commercial Officer | 330.20K | $4.14M | Feb 26, 2025 | |
| Merendino Lauren | Chief Commercial Officer | 90.00K | $1.30M | Feb 26, 2025 | |
| Merendino Lauren | Chief Commercial Officer | 90.00K | $1.07M | Feb 26, 2025 | |
| Merendino Lauren | Chief Commercial Officer | 55.31K | $- | Feb 26, 2025 | |
| York Charles N Ii | Coo, Cfo And Secretary | M-Exempt | 6.62K | $- | Feb 15, 2025 |
| York Charles N Ii | Coo, Cfo And Secretary | S-Sale | 4.37K | $52.28K | Feb 18, 2025 |
| York Charles N Ii | Coo, Cfo And Secretary | M-Exempt | 6.62K | $- | Feb 15, 2025 |
| York Charles N Ii | Coo, Cfo And Secretary | M-Exempt | 2.25K | $- | Feb 15, 2025 |
| York Charles N Ii | Coo, Cfo And Secretary | M-Exempt | 1.38K | $- | Feb 15, 2025 |
Recent Position Changes
| Institution | Shares Changed | % Change | Date |
|---|---|---|---|
| FMR | +5.48M | +73.86% | Feb 13, 2025 |
| ALYESKA | +2.51M | +100.00% | Feb 14, 2025 |
| RA | -2.12M | -26.88% | Feb 14, 2025 |
| BlackRock | +1.45M | +30.72% | Feb 07, 2025 |
| GOLDMANCHS | -1.30M | -73.38% | Feb 11, 2025 |
| +1.19M | +100.00% | Feb 14, 2025 | |
| MARSHALL WACE, LLP | +1.10M | +100.00% | Feb 13, 2025 |
| VESTAL POINT | -1.06M | -42.40% | Feb 14, 2025 |
| ESTUARY | +973.00K | +35.46% | Feb 14, 2025 |
| JANUS HENDERSON | -870.98K | -40.00% | Feb 14, 2025 |
Recent Ownership Filings
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 21, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 21, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 21, 2025
144
Form 144 - Report of proposed sale of securities
Feb 18, 2025
144
Form 144 - Report of proposed sale of securities
Feb 18, 2025
144
Form 144 - Report of proposed sale of securities
Feb 18, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 31, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 31, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 31, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Dec 12, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Nov 19, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Nov 19, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Nov 19, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Nov 19, 2024
144
Form 144 - Report of proposed sale of securities
Nov 18, 2024
144
Form 144 - Report of proposed sale of securities
Nov 18, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Nov 12, 2024
144
Form 144 - Report of proposed sale of securities
Nov 12, 2024
Related Metrics
Explore detailed financial metrics and analysis for DAWN.